NUNZIA PHARMACEUTICAL COMPANY — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7ae59d62-c2dd-4e61-b668-c9f6f23f8afd/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-78.1M | 2021-01-01 – 2021-12-31 | evidence 0001683168-22-002707 |
| FY 2020 | $-101.0M | 2020-01-01 – 2020-12-31 | evidence 0001683168-22-002045 |
| FY 2019 | $-33.6k | 2019-01-01 – 2019-12-31 | evidence 0001562884-21-000047 |
| FY 2018 | $-18.6k | 2018-01-01 – 2018-12-31 | evidence 0001562884-19-000012 |
| FY 2017 | $-13.0k | 2017-01-01 – 2017-12-31 | evidence 0001562884-19-000012 |
| FY 2015 | $-750 | 2015-01-01 – 2015-12-31 | evidence 0001562884-19-000012 |
| FY 2014 | $-28.7k | 2014-01-01 – 2014-12-31 | evidence 0001562884-19-000012 |
| FY 2013 | $-28.7k | 2013-01-01 – 2013-12-31 | evidence 0001562884-19-000012 |
| FY 2012 | $-7.4k | 2012-01-01 – 2012-12-31 | evidence 0001562884-19-000012 |
| FY 2011 | $-30.7k | 2011-01-01 – 2011-12-31 | evidence 0001562884-19-000012 |
| FY 2010 | $-71.3k | 2010-01-01 – 2010-12-31 | evidence 0001562884-19-000012 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NUNZIA PHARMACEUTICAL COMPANY — all facts · Revenue · Operating Income